01
Low NADAC$525.89
→
Avg plan cost$532.43
Part D spend $12.31B
1× spread, current vs floor
Class summary at a glance.
Every drug in the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $12.31Bcombined across class
- Total Rx claims
- 9.7M2.1M unique beneficiaries
- Generic mfrs (active)
- 0across all molecules